Veradigm

Veradigm Capital Intensity

The Capital Intensity Ratio of Veradigm (MDRX) as of Nov 4, 2026 is 255.90 %. In the previous year, Capital Intensity Ratio was 255.90 % — a change of 0.00% (lower).

Capital Intensity

255.90 %

YoY

0.00%

Last updated:

Capital Intensity Ratio of Veradigm is 2024 255.90 % . Capital Intensity Ratio of Veradigm was 2023 255.90 % . It decreases by 0.00% lower compared to the previous year.

The Veradigm Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2016
247.25 USD
Jan 1, 2017
282.44 USD
Jan 1, 2018
181.80 USD
Jan 1, 2019
196.36 USD
Jan 1, 2020
194.16 USD
Jan 1, 2021
420.01 USD
Jan 1, 2022
255.90 USD
Jan 1, 2024
255.90 USD
The Veradigm Capital Intensity history
YEARCapital IntensityYoY
255.90 %0.00%
255.90 %-39.07%
420.01 %+116.32%
194.16 %-1.12%
196.36 %+8.00%
181.80 %-35.63%
282.44 %+14.23%
247.25 %+27.82%
193.44 %+8.16%
178.85 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Veradigm Stock analysis

What does Veradigm do? Allscripts Healthcare Solutions Inc is one of the leading companies in the digital healthcare sector in the USA. The company was founded in 1982 and has since become one of the most important providers of IT solutions in healthcare. Allscripts supports healthcare providers in improving patient care and efficiency through the development and provision of innovative software and IT solutions. The business model of Allscripts is based on the development and sale of web-based software solutions for medical documentation and hospital management. These solutions are mainly distributed to hospitals and practices through subscriptions or licenses. Allscripts offers a variety of products that focus on various areas of medical care. One of the main divisions of the company is the electronic health records system (EHR). This system allows for the electronic recording, storage, and management of medical data and information. This enables healthcare providers to quickly and easily access patient information and document important diagnoses and treatments. Another important division of Allscripts is the Revenue Cycle Management (RCM), which optimizes billing and payment processes in hospitals and practices. In addition, Allscripts also offers solutions for telemedicine, including patient portal applications, remote patient monitoring systems, and mobile apps for patients and providers. Allscripts is based in Chicago and employs over 10,000 employees in various countries. The company also maintains partnerships with other companies in healthcare to facilitate and improve the complexity of digital transformation in the healthcare market. This includes companies like Microsoft, who work together with Allscripts on the development of artificial intelligence for healthcare applications. Allscripts' portfolio of offerings is very broad and provides customers with a variety of software solutions for different areas of medical care. The products are particularly characterized by their user-friendly interfaces, flexibility, and scalability. This allows customers to customize the solutions to their specific needs and consider future requirements. However, some products have been criticized for their expandability, poor design, and slow loading times. Recently, Allscripts has made a number of investments in research and development to address these issues and optimize the applications. In summary, Allscripts Healthcare Solutions Inc is considered one of the leading providers of software and IT solutions in healthcare in the USA. Thanks to a wide range of products and close collaboration with partners in healthcare, Allscripts is able to offer its customers innovative and scalable solutions that help them optimize their business processes and improve the quality of their medical care. Veradigm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Veradigm stock

Capital Intensity Ratio of Veradigm is 255.90 % in 2024.

Capital Intensity Ratio of Veradigm changed from 255.90 % to 255.90 %, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Veradigm since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Veradigm with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Veradigm

All Key Metrics — Veradigm